CA9 and triple-negative breast carcinoma: For example, CAIX promotes cell motility in cervical cancer through the ERK/PFKFB4 pathway [78], its inhibition in triple-negative breast cancer reduces lung metastasis [75], and suppression of the HIF1α/CAIX axis in epithelial ovary cancer reduces malignancy and invasion [79].